Active Ingredient: RISEDRONATE SODIUM
Proprietary Name: ATELVIA
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 35MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022560
Product Number: 001
Approval Date: Oct 8, 2010
Applicant Holder Full Name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
